News
-
-
COMMUNIQUÉ DE PRESSE
Ipsen delivers strong sales in the first nine months of 2025 and further upgrades its full-year guidance
Ipsen reports strong sales growth in first nine months of 2025, upgrades full-year guidance, and announces acquisition of ImCheck Therapeutics. Financial results and pipeline updates detailed -
COMMUNIQUÉ DE PRESSE
IPSEN - Buy-back programme - Art 5 of MAR - Week 40 - 2025
-
-
COMMUNIQUÉ DE PRESSE
IPSEN - Buy-back programme - Art 5 of MAR - Week 37 - 2025
-
-
COMMUNIQUÉ DE PRESSE
IPSEN - Buy-back programme - Art 5 of MAR - Week 33 - 2025
-
COMMUNIQUÉ DE PRESSE
IPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2025
-
-